Apellis Pharmaceuticals, Inc. reports

Company location: Waltham, MA
Fiscal year end: 31 December

Apellis Pharmaceuticals, Inc. has filed 1,229 SEC EDGAR filings since 21 May 2010

Filter by type:
10-K
10-Q
8-K
SC13G

SEC filing history

Showing 801-825 of 1,000 matching filings.

Per page

25

Current page

33

4

PRIMARY DOCUMENT

Filing date: 01 Feb 2022
Reporting date: 28 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 01 Feb 2022
Reporting date: 28 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 01 Feb 2022
Reporting date: 28 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 01 Feb 2022
Reporting date: 28 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jan 2022
Reporting date: 21 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jan 2022
Reporting date: 21 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jan 2022
Reporting date: 21 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jan 2022
Reporting date: 21 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jan 2022
Reporting date: 21 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jan 2022
Reporting date: 21 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jan 2022
Reporting date: 21 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jan 2022
Reporting date: 21 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jan 2022
Reporting date: 21 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jan 2022
Reporting date: 21 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jan 2022
Reporting date: 21 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jan 2022
Reporting date: 21 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jan 2022
Reporting date: 21 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 24 Jan 2022
Reporting date: 21 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38276

8-K

Filing date: 20 Jan 2022
Reporting date: 20 Jan 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

424B5 File 333-235830

424B5

Filing date: 20 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 Jan 2022
Reporting date: 14 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 Jan 2022
Reporting date: 14 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 14 Jan 2022
Reporting date: 12 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38276

8-K

Filing date: 10 Jan 2022
Reporting date: 10 Jan 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 04 Jan 2022
Reporting date: 01 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .